CORRELATION OF KI-67 PROLIFERATIVE INDEX WITH ONCOTYPE DX RECURRENCE SCORE IN HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE EARLY BREAST CANCER WITH LOW-BURDEN AXILLARY NODAL DISEASE -- A REVIEW OF 137 CASESdoi:10.5114/pjp.2024.135859...
The recent classification system of NETs proposed by the European Neuroendocrine Tumor Society (ENETS) utilises Ki-67 proliferation index and/or mitotic count to assign grade (low, intermediate, high). It has been adopted into routine practice but there is limited data on the relationship between...
For whole slides, the Ki-67 proliferation index, referred to hereafter as the Ki-67 score, was the percentage of positively stained nuclei scored according to three methods: whole slide, hot spot, and invasive edge scoring. For manual scoring, the percentage of positively stained nuclei within ...
The tumour labelling index ranged from 1 to 80 per cent positivity: there was also heterogeneity of labelling within many of the tumours. There was no correlation between Ki-67 derived proliferative score and known prognostic parameters, including Dukes stage, New Prognostic Classification grade, ...
KI-67 is one of the proliferative markers strongly linked to cell cycle control. During mitosis, this protein is tightly regulated by protease upon completion of its activity, such that its half life is less than 90 minutes [14,15]. It is expressed in all proliferative cells both in normal...
We conclude that MIB-1 LI and TGFα score are important... 展开 关键词: immunocytochemistry MIB-1 proliferative index transforming growth factor-α 被引量: 84 年份: 1998 收藏 引用 批量引用 报错 分享 全部来源 求助全文 EBSCO 相似文献 参考文献 引证文献...
This cohort study of patients with breast cancer investigates whether Ki-67 expression correlates with the 21-gene recurrence score (RS) and whether high
Cox-2, PR and Ki-67 immunohistochemistry were performed. Immunohistochemical score (Cox-2, PR) and proliferative index (Ki-67) were analysed.ResultsThe majority of our patients were female (68%) and of Chinese ethnicity (44.3%). Most tumours were WHO grade 1 (92.5%), meningot...
The proliferation marker Ki-67 is one of the most controversially discussed parameters for treatment decisions in breast cancer patients. The purpose of this study was to evaluate the routine use and value of Ki-67 as a prognostic marker, and to analyze the associations between Ki-67 and ...
Proliferative activity of NSCLC and survival: opposing effects of low and high Ki-67 indices. In most published studies mean or median PI has been used for stratification of cases according to proliferative activity. Applying these categories to our test cohort did not yield significant differences ...